Publications
Professor Torbjörn Bäckström, Founder and Chief Science Officer, Asarina Pharma and Senior Professor in Obstetrics and Gynecology, University of Umeå
Publications
2021
A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder
Psychoneuroendocrinology
Torbjörn Bäckström, Karin Ekberg, Angelica Lindén Hirschberg, Marie Bixo , C. Neill Epperson, Paula Briggs, Nick Panay, Shaughn O’Brien
Link: https://www.sciencedirect.com/science/article/pii/S0306453021003000
2017
Treatment of premenstrual dysphoric disorder with the GABA-A receptor modulating steroid antagonist Sepranolone (UC1010)—A randomized controlled trial
Psychoneuroendocrinology
Marie Bixo, Karin Ekberg, Inger Sundström Poromaa, Angelica Lindén Hirschberg, Aino Fianu Jonasson, Lotta Andréen, Erika Timby, Marianne Wulff, Agneta Ehrenborg, Torbjörn Bäckström
2015
GABA-A Receptor-Modulating Steroids in Relation to Women’s Behavioral Health
Curr Psychiatry Rep
Torbjörn Bäckström, Marie Bixo, Jessica Strömberg
Link: https://pubmed.ncbi.nlm.nih.gov/26396092/
2014
Allopregnanolone and mood disorders
Progress in Neurobiology
T.Bäckström, M.Bixo, M.Johansson, S.Nyberg, L.Ossewaarde, G.Ragagnin, I.Savic, J.Strömberg, E.Timby, F.van Broekhoven, G.van Wingen
Link: https://www.sciencedirect.com/science/article/abs/pii/S0301008213000671